Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,305 | -4,225 | -3,228 | -16,555 | N/A |
| Other Working Capital | 444 | 196 | 22 | 121 | N/A |
| Other Operating Activity | 1,199 | 1,011 | 525 | 13,807 | 0 |
| Operating Cash Flow | $-4,662 | $-3,018 | $-2,681 | $-2,628 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 122 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 8,175 | 10,332 | N/A | 4,706 | N/A |
| Other Financing Activity | -116 | -985 | -206 | 4,831 | 0 |
| Financing Cash Flow | $8,182 | $9,347 | $-206 | $9,536 | $N/A |
| Exchange Rate Effect | 3 | -9 | -2 | N/A | N/A |
| Beginning Cash Position | 13,214 | 6,893 | 9,782 | 2,873 | N/A |
| End Cash Position | 16,737 | 13,214 | 6,893 | 9,782 | N/A |
| Net Cash Flow | $3,523 | $6,321 | $-2,889 | $6,909 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,662 | -3,018 | -2,681 | -2,628 | N/A |
| Free Cash Flow | -4,662 | -3,018 | -2,681 | -2,628 | 0 |